Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled GM-CSF in Autoimmune PAP Patients
NCT00901511Phase 2Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Jul 2009
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in autoimmune pulmonary alveolar proteinosis (aPAP), sponsored by IRCCS San Matteo Foundation. Started Jul 2009; status: completed.
02
Drugs
sargramostim
03
Conditions
autoimmune pulmonary alveolar proteinosis (aPAP)
Beyond the preview
Go deeper on NCT00901511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00901511.